0 Comentários
0 Compartilhamentos
1426 Visualizações
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça o login para curtir, compartilhar e comentar!
- Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comentários 0 Compartilhamentos 866 Visualizações
- Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comentários 0 Compartilhamentos 763 Visualizações
- Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 427 Visualizações
- GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Comentários 0 Compartilhamentos 728 Visualizações
- North America Allergy Immunotherapy Market Size, Share, Growth Forecast, 2032Among the most dependable areas of healthcare investment stands the global North America Allergy Immunotherapy market within the medical device industry, with the greatest transformative capacity for expansion and innovation. A modern healthcare setup reflects advances in the equipment to enable quick treatments and pinpoint accuracy in results. The global North America Allergy Immunotherapy...0 Comentários 0 Compartilhamentos 4235 Visualizações
© 2026 Mạng xã hội kotra-hanoi.org.vn
Portuguese (Brazil)